ACHONDROPLASIA

Clinical trials for ACHONDROPLASIA explained in plain language.

Never miss a new study

Get alerted when new ACHONDROPLASIA trials appear

Sign up with your email to follow new studies for ACHONDROPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 7 Completed 4 Terminated 1

New daily pill aims to boost growth in kids with dwarfism

Disease control Not yet recruiting

This study tests a new drug called ABSK061 in children aged 3 to 12 with achondroplasia, a common form of dwarfism. The drug is taken once daily and aims to improve growth rate. The trial will first find a safe dose, then check how well it works over a year. About 110 children wi…

Matched conditions: ACHONDROPLASIA

Phase: PHASE1, PHASE2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

ACHONDROPLASIA

Get alerted when new ACHONDROPLASIA trials appear

New daily pill aims to boost growth in kids with dwarfism